MedPath

Evaluation of the exercise programs for childhood cancer patients offered by the German Sports University Cologne in the Children’s Hospital Amsterdamer Straße

Not Applicable
Recruiting
Conditions
pediatric cancer
C00-D48
Neoplasms
Registration Number
DRKS00015317
Lead Sponsor
Deutsche Sporthochschule KölnInstitut für Kreislaufforschugn und Sportmedizin, Abteilung Molekulare und Zelluläre Sportmedizin
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Inclusion criteria (for all patient groups, PG1, Pg2 and PG3)
• Age between 2 and 22 years
• Childhood cancer disease
• Medical treatment at the Children's hospital Amsterdamer Straße, Cologne
• medical clearance of the treating physician
• informed consent from the legal guardian and the participant

Inclusion criteria (for all healthy comparison groups, GG1 and GG2)
• Age between 2 and 22 years
• Healthy siblings or friends of a childhood cancer patient
• informed consent from the legal guardian and the participant

Exclusion Criteria

exclusion criteria (for all groups)
• specific impairments (following physician’s advice)

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Adherence (documentation of the number of offered and attended sessions)
Secondary Outcome Measures
NameTimeMethod
• Reasons for non-participation at the training sessions or study drop out (continuous documentation)<br>• Reasons for training cancellation (continuous documentation)<br>• Intensity of training sessions (heart rate monitoring during training sessions; assessment of perceived exertion using BORG-scale)<br>• Session protocols (continuous documentation of performed exercises)<br>• Physical condition (assessment of perceived physical condition before and at the end of each training session using a three-stage smiley-scale)<br>• adverse events (documentation of exercise-related adverse events leading to health deteriorations <br>• program satisfaction (assessment of program satisfaction using a self-developed questionnaire)<br>• motor performance testing (MOT 4-6 or DMT 6-18; performed after cessation of inpatient cancer treatment)
© Copyright 2025. All Rights Reserved by MedPath